A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells

Koji Koike, Takeshi Kawabe, Toshiya Tanaka, Satoshi Toh, Takeshi Uchiumi, Morimasa Wada, Shin Ichi Akiyama, Mayumi Ono, Michihiko Kuwano

Research output: Contribution to journalArticle

242 Citations (Scopus)

Abstract

The human cMOAT gene encodes a membrane protein involved in the ATP- dependent transport of hydrophobic compounds. To determine whether cMOAT is associated with drug sensitivity, we transfected an expression vector containing cMOAT antisense cDNA into the HepG2 human hepatic cancer cell line. We observed a reduction in cMOAT protein, as well as an enhanced level of glutathione, in the antisense transfectants. The transfectants displayed an increased sensitivity to cisplatin, vincristine, doxorubicin, and the camptothecin derivatives, (4S)-4,11-diethyl-4-hydroxy-9-[(4- piperidinopiperidino)carbonyloxy]dione hydrochloride triethydrate and 7- ethyl-10-hydroxycamptothecin, but not to etoposide, 3-[4-amino-2-methyl-5- pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea, 5-fluorouracil, and mitomycin C. Results suggest that cMOAT levels are inversely correlated with those of glutathione, and that cMOAT and its related genes may be involved in the sensitivity of cells to certain anticancer agents.

Original languageEnglish
Pages (from-to)5475-5479
Number of pages5
JournalCancer Research
Volume57
Issue number24
Publication statusPublished - Dec 15 1997

Fingerprint

Liver Neoplasms
Hepatocytes
Complementary DNA
Pharmaceutical Preparations
irinotecan
Glutathione
Camptothecin
Mitomycin
Vincristine
Etoposide
Fluorouracil
Antineoplastic Agents
Doxorubicin
Cisplatin
Genes
multidrug resistance-associated protein 2
Membrane Proteins
Adenosine Triphosphate
Cell Line
Proteins

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. / Koike, Koji; Kawabe, Takeshi; Tanaka, Toshiya; Toh, Satoshi; Uchiumi, Takeshi; Wada, Morimasa; Akiyama, Shin Ichi; Ono, Mayumi; Kuwano, Michihiko.

In: Cancer Research, Vol. 57, No. 24, 15.12.1997, p. 5475-5479.

Research output: Contribution to journalArticle

Koike, K, Kawabe, T, Tanaka, T, Toh, S, Uchiumi, T, Wada, M, Akiyama, SI, Ono, M & Kuwano, M 1997, 'A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells', Cancer Research, vol. 57, no. 24, pp. 5475-5479.
Koike, Koji ; Kawabe, Takeshi ; Tanaka, Toshiya ; Toh, Satoshi ; Uchiumi, Takeshi ; Wada, Morimasa ; Akiyama, Shin Ichi ; Ono, Mayumi ; Kuwano, Michihiko. / A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. In: Cancer Research. 1997 ; Vol. 57, No. 24. pp. 5475-5479.
@article{57d26eb7724146b8936141c7e2943168,
title = "A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells",
abstract = "The human cMOAT gene encodes a membrane protein involved in the ATP- dependent transport of hydrophobic compounds. To determine whether cMOAT is associated with drug sensitivity, we transfected an expression vector containing cMOAT antisense cDNA into the HepG2 human hepatic cancer cell line. We observed a reduction in cMOAT protein, as well as an enhanced level of glutathione, in the antisense transfectants. The transfectants displayed an increased sensitivity to cisplatin, vincristine, doxorubicin, and the camptothecin derivatives, (4S)-4,11-diethyl-4-hydroxy-9-[(4- piperidinopiperidino)carbonyloxy]dione hydrochloride triethydrate and 7- ethyl-10-hydroxycamptothecin, but not to etoposide, 3-[4-amino-2-methyl-5- pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea, 5-fluorouracil, and mitomycin C. Results suggest that cMOAT levels are inversely correlated with those of glutathione, and that cMOAT and its related genes may be involved in the sensitivity of cells to certain anticancer agents.",
author = "Koji Koike and Takeshi Kawabe and Toshiya Tanaka and Satoshi Toh and Takeshi Uchiumi and Morimasa Wada and Akiyama, {Shin Ichi} and Mayumi Ono and Michihiko Kuwano",
year = "1997",
month = "12",
day = "15",
language = "English",
volume = "57",
pages = "5475--5479",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "24",

}

TY - JOUR

T1 - A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells

AU - Koike, Koji

AU - Kawabe, Takeshi

AU - Tanaka, Toshiya

AU - Toh, Satoshi

AU - Uchiumi, Takeshi

AU - Wada, Morimasa

AU - Akiyama, Shin Ichi

AU - Ono, Mayumi

AU - Kuwano, Michihiko

PY - 1997/12/15

Y1 - 1997/12/15

N2 - The human cMOAT gene encodes a membrane protein involved in the ATP- dependent transport of hydrophobic compounds. To determine whether cMOAT is associated with drug sensitivity, we transfected an expression vector containing cMOAT antisense cDNA into the HepG2 human hepatic cancer cell line. We observed a reduction in cMOAT protein, as well as an enhanced level of glutathione, in the antisense transfectants. The transfectants displayed an increased sensitivity to cisplatin, vincristine, doxorubicin, and the camptothecin derivatives, (4S)-4,11-diethyl-4-hydroxy-9-[(4- piperidinopiperidino)carbonyloxy]dione hydrochloride triethydrate and 7- ethyl-10-hydroxycamptothecin, but not to etoposide, 3-[4-amino-2-methyl-5- pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea, 5-fluorouracil, and mitomycin C. Results suggest that cMOAT levels are inversely correlated with those of glutathione, and that cMOAT and its related genes may be involved in the sensitivity of cells to certain anticancer agents.

AB - The human cMOAT gene encodes a membrane protein involved in the ATP- dependent transport of hydrophobic compounds. To determine whether cMOAT is associated with drug sensitivity, we transfected an expression vector containing cMOAT antisense cDNA into the HepG2 human hepatic cancer cell line. We observed a reduction in cMOAT protein, as well as an enhanced level of glutathione, in the antisense transfectants. The transfectants displayed an increased sensitivity to cisplatin, vincristine, doxorubicin, and the camptothecin derivatives, (4S)-4,11-diethyl-4-hydroxy-9-[(4- piperidinopiperidino)carbonyloxy]dione hydrochloride triethydrate and 7- ethyl-10-hydroxycamptothecin, but not to etoposide, 3-[4-amino-2-methyl-5- pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea, 5-fluorouracil, and mitomycin C. Results suggest that cMOAT levels are inversely correlated with those of glutathione, and that cMOAT and its related genes may be involved in the sensitivity of cells to certain anticancer agents.

UR - http://www.scopus.com/inward/record.url?scp=0031468814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031468814&partnerID=8YFLogxK

M3 - Article

C2 - 9407953

AN - SCOPUS:0031468814

VL - 57

SP - 5475

EP - 5479

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 24

ER -